Adam S. Grossman - Jan 4, 2023 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Signature
/s/ Adam S. Grossman, by Brian Lenz as Attorney-in-fact
Stock symbol
ADMA
Transactions as of
Jan 4, 2023
Transactions value $
-$645,775
Form type
4
Date filed
1/6/2023, 08:00 PM
Previous filing
Dec 9, 2022
Next filing
Mar 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Tax liability -$646K -167K -7.57% $3.87 2.04M Jan 4, 2023 Direct F1, F2, F3
holding ADMA Common Stock 1.14M Jan 4, 2023 See Footnote F4
holding ADMA Common Stock 581K Jan 4, 2023 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 300,000 RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 453,750 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs") which will vest in eight (8) equal quarterly installments over a period of two years following December 31, 2022, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;
F2 (continued from footnote 1) (iii) 162,893 unvested RSUs granted on February 25, 2021, of which 137,362 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 25,531 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting;
F3 (continued from footnote 2) (iv) 50,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (v) 1,070,198 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.
F4 These shares are owned by Areth, LLC ("Areth"). The reporting person is a control person of Areth.
F5 These shares are owned by Hariden, LLC ("Hariden"). The reporting person is the managing member of Hariden.